Immunity Support Complex
Commercial- Indications
- Immune support
Company intelligence / Profile preview
Biovanta
New York City, New York, United Statesbiovanta.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Biovanta’s lead over-the-counter cold relief and immunity support products are clinically proven to reduce the severity of common cold symptoms by up to ~60–70% compared to placebo in a randomized double-blind clinical trial involving over 150 participants across six US cities. The active ingredients modulate inflammatory pathways and strengthen the respiratory barrier. Peer-reviewed studies show superiority over traditional OTC drugs at controlling upper respiratory inflammation. Pipeline includes novel anti-inflammatory/antiviral formulas in preclinical development.
- Therapeutic areas
- PulmonologyInfectious Diseases
- Modalities
- Natural bioactive compounds (including lactoferrin, lysozyme, aloe, salicylates/aspirin)Immune complexes
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
No major pharma partnerships disclosed; part of NYU Biolabs incubator affiliated with NYU Langone Medical Center.
Beyond the preview
Go deeper on Biovanta.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biovanta.